A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

NCT00457782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma
Chronic Lymphocytic Leukaemia
B-cell Non-Hodgkin's Lymphoma

Interventions

DRUG: KW-2478

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]